Clinical Trials List
2025-11-15 - 2030-03-31
Phase I
Not yet recruiting3
ICD-10N00.0
Acute nephritic syndrome with minor glomerular abnormality
ICD-10N00.1
Acute nephritic syndrome with focal and segmental glomerular lesions
ICD-10N00.2
Acute nephritic syndrome with diffuse membranous glomerulonephritis
ICD-10N00.3
Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
ICD-10N00.4
Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10N00.5
Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
ICD-10N00.6
Acute nephritic syndrome with dense deposit disease
ICD-10N00.7
Acute nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-9580.0
Acute glomerulonephritis, with lesion of proliferative glomerulonephritis
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 呂政勳 Division of General Internal Medicine
- 鄭喬峯 Division of General Internal Medicine
- 郭佑民 Division of General Internal Medicine
- CHIEH-YU SHEN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 曹彥博 風濕免疫科
- Wei-Sheng Chen 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yi-Ming Chen Division of Rheumatology
- 洪維廷 Division of Rheumatology
- 高宗楙 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 許鶴忀 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 陳韻文 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 譚國棟 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 曾智偉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
36 participants